版本:
中国

BRIEF-Moleculin Biotech announces plan for clinical trial drug production

Oct 7 Moleculin Biotech Inc

* Has secured an agreement with Dermin Sp. Zo. O. ("Dermin") to utilize Dermin's supply of Annamycin for its upcoming clinical trial

* Agreement reached allows company to utilize Annamycin in upcoming clinical trials rather than having to produce new Annamycin for own use

* Expanded clinical trials on Annamycin by first half of 2017

* Company plans to begin expanded clinical trials on Annamycin by first half of 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐